搜索结果: 1-13 共查到“知识库 细胞生物学 cancer”相关记录13条 . 查询时间(0.109 秒)
近日，皖南医学院第一附属医院神经系统疾病医学转化中心研究团队与新加坡国立大学杨潞龄医学院（NUS Yong Loo Lin School of Medicine）Chen Xiaoyuan Shawn（陈小元）教授团队、东南大学中大医院生命健康高等研究院夏洪平教授团队紧密合作，在《Nature Cancer》发表了题为“An in vitro-transcribed circular RNA ta...
肿瘤学顶级期刊《Clinical Cancer Research》（影响因子13.801；17/245，Oncology，Q1）近日在线发表北京航空航天大学医学科学与工程学院，生物医学工程高精尖创新中心于健教授团队、陈伟副教授团队及北京高博博仁医院克晓燕、胡凯主任团队合作的最新研究成果“Single-cell transcriptomics reveals immune reconstitutio...
Cancer Immunol. Res.|上海市免疫学研究所王锋团队解析TCR复合体信号机制，开发增强型TCR-T免疫治疗新策略（图）
细胞膜 细胞活化 酪氨酸 上海市免疫学研究所
2023/4/12
TCR作为T细胞活化的第一信号通过识别抗原-MHC启动跨膜信号，触发位于CD3胞质段（cytoplasmic domain, CD3CD）的免疫受体酪氨酸激活基序（immunoreceptor tyrosine-based activation motifs, ITAMs）磷酸化，从而激活T细胞下游的系列反应介导特异性免疫应答。
选择性多聚腺苷酸化 (Alternative polyadenylation，APA) 是真核生物中普遍存在的一种转录调控机制，能调控基因互作和表达且广泛参与肿瘤发展1。研究团队已有研究揭示相比肿瘤样本，体外培养的癌细胞系整体基因的3’UTR缩短，并揭示了APA 的变化可以影响细胞对多种抗癌药物的敏感性，与癌症病人临床分期和预后等高度相关2。相关研究也揭示APA 参与调节各种免疫细胞的免疫反应，以...
树突状细胞（DC）疫苗是目前在临床上应用的一种肿瘤治疗疫苗，其制备过程一般都在病人体外进行，病人来源的DC在体外进行诱导分化后再回输给病人，这种疫苗制备过程十分复杂，容易被污染，不同的技术人员、不同条件的实验室制备的疫苗疗效差异较大，较难标准化，因此体外制备的DC疫苗很难在临床推广应用。
2020年4月16日，Journal for ImmunoTherapy of Cancer (JITC)杂志在线发表了上海交通大学医学院上海市免疫学研究所李斌课题组和复旦大学附属妇产科医院乳腺外科吴克瑾课题组合作的成果“Targeting ANXA1 abrogates Treg-mediated immune suppression in triple-negative breast canc...
Stiffness and Modulus and Independent Controllers of Breast Cancer Metastasis
cancer biomaterials collagen mechanosensing
2014/12/12
One out of eight women in the United States will develop breast cancer during their lifetime. Ninety percent of cancer related deaths are due to metastasis. Metastasis is the biological process where ...
The study of retinoic acids and Rhodiola as potential chemopreventional and chemotherapeutic reagents of breast cancer
Cancer breast cancer the female cancer mortality
2014/12/11
According to the National Cancer Institute, breast cancer is second only to lung cancer in cancer-related deaths for women in the United States (American Cancer Society). Despite a gradual decline in ...
Hormones, growth factors, and the regulation of tumor suppressor pathways involved in parity -induced protection of breast cancer
Women with breast cancer cases diagnosis and reproduction exogenous hormones ionizing radiation genetic factors
2014/12/11
Despite current advances in understanding breast cancer, in 2007 an estimated 178,480 new cases were diagnosed in female patients in the United States, and an estimated 40,640 deaths will occur due to...
From Mouse Mammary Tumor Model to New Therapeutic Method ---Mammary Tumor Development in Balb/c-Trp53+/- Mice and Magnetic Nanoparticle Induced Heating for Cancer Treatment
Breast cancer Magnetic nanoparticle Mammary gland Mouse tumor model Stem cell Thermotherapy
2014/12/10
PATHWAYS CONTRIBUTING TO DEVELOPMENT OF SPONTANEOUS MAMMARY TUMORS IN BALB/c-Trp53+/- MICE Mutation and loss of p53 function are common features among human breast cancers. We use BALB/c-Trp53+/- mice...
Effects of Phytochemicals from Rhodiola crenulata on Highly Invasive Breast Cancer Cell Lines and Embryonic Models of Migration
Cancer Mammary Metabolism Metastasis Natural Product Rhodiola crenulata
2014/12/10
The root of the Tibetan plant Rhodiola crenulata is part of eastern traditional medicine. Studies have suggested that members of the Rhodiola genus display anticancer properties. In this study we exam...
Regulation and Action of Skp2 and Rhoa in Cell and Tumor Models: Investigation into the Molecular Mechanisms Responsible for the Aggressive Phenotype of Triplenegative Breast Cancer
Basal-Like Breast Cancer Cell Cycle p27 proliferation SKP2 Triple-Negative Breast Cancer
2014/12/10
Breast cancer tops the list of new cancer cases and is predicted to be the second leading cause of cancer deaths in women in 2012. The primary objective of the present study was to provide insights in...
ACQUIRED STAT4 DEFICIENCY AS A CONSEQUENCE OF CANCER CHEMOTHERAPY
STAT4 Lymphoma Chemotherapy
2015/5/22
Signal Transducer and Activator of Transcription 4 (STAT4) is an important transcription factor activated by IL-12 signaling. Activated STAT4 is essential for Th1 cell differentiation, a process chara...